Abstract:Abstract Background Infants covered by Medicaid have higher RSV hospitalization rates compared with those of commercial insurance, but findings are limited to the inpatient setting. This birth cohort study describes healthcare encounters for RSV across all settings among infants covered by Medicaid and CHIP. Methods Medicaid claims for infants born and residing in AZ, CA, FL, MI, NC, NY, and TX were analyzed for first diagnosis of RSV in 2016-2018 using ICD-10 codes. Encounters on the day of first diagnosis were examined by setting in seven states and by setting and race in CA, FL, and NC. Results 80,945 infants were diagnosed with RSV in seven states in 2016-2018. The highest encounter rates for first RSV diagnosis were in the emergency department (ED) in five states (11.0-33.4 per 1000 in AZ, CA, FL, MI, NY) and outpatient setting in two states (54.8 and 68.5 per 1000 in TX, NC). Significantly higher outpatient encounter rates were found in CA and NC for White infants compared to Non-White infants. In NC, ED encounter rates were significantly higher for Non-White infants compared to White infants, while in CA, the rates were comparable. In these two states, hospitalization rates were similar across groups. In FL, compared with White infants, Non-White infants had significantly higher encounter rates in each setting on the day of first RSV diagnosis. Conclusions This is the first study to describe the burden of RSV by setting and race. Medicaid infants who are newly diagnosed with RSV have the highest burden in ED and outpatient settings.

Health Care Utilization Among Infants Covered By Medicaid and Newly Diagnosed with Respiratory Syncytial Virus